mRNA. Network pharmacology, molecular docking, and dynamics simulations revealed AKR1C1 as a potential upstream target modulating ferroptosis. This work provides a scientific basis for developing SAC into functional neuroprotective agents and supports its value-added utilization as an agricultural resource.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: